Lipid-lowering therapy: who can benefit
Author:
Open Access
- 1 August 2011
- journal article
- review article
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. 7, 525-34
Abstract
Peer reviewed article authored by (Lewis SJ). Read article or submit your manuscript for publishing.Keywords
This publication has 50 references indexed in Scilit:
- Association of Temporal Trends in Risk Factors and Treatment Uptake With Coronary Heart Disease Mortality, 1994-2005JAMA, 2010
- Heart Disease and Stroke Statistics—2010 UpdateCirculation, 2010
- An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Atherosclerosis: the underlying disease.2009
- Primary Prevention of Cardiovascular Mortality and Events With Statin TreatmentsJACC, 2008
- Preventing Heart Disease in the 21st CenturyCirculation, 2008
- Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000New England Journal of Medicine, 2007
- Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet, 2004
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesJACC, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998